« Back to Record
Citation APA

Ferenci, P., Bernstein, D., Lalezari, J., Nyberg, A., Enayati, P., Green, S., Hassanein, T., Cohen, D., Luo, Y., Xie, W., King, M., Podsadecki, T., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Box, T. T., Younes, Z., Baruch, Y., Bhandari, B. R., Caruntu, F. A., Sepe, T., Chulanov, V., Janczewska, E., Rizzardini, G., Gervain, J., Planas, R., Moreno, C., & Reddy, K. R. (2014). ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV. The New England journal of medicine, 370(21), 1983-1992. doi:10.1056/NEJMoa1402338


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/187130

Ferenci, P., Bernstein, D., Lalezari, J., Nyberg, A., Enayati, P., Green, S., Hassanein, T., Cohen, D., Luo, Y., Xie, W., King, M., Podsadecki, T., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Box, T. T., Younes, Z., Baruch, Y., Bhandari, B. R., Caruntu, F. A., Sepe, T., Chulanov, V., Janczewska, E., Rizzardini, G., Gervain, J., Planas, R., Moreno, C., & Reddy, K. R. (2014). ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV. The New England journal of medicine, 370(21), 1983-1992. doi:10.1056/NEJMoa1402338